ID
16556
Beschreibung
MIPSO Vergleichende Untersuchung der bakteriellen Mikrobiota in der Haut sowie dem Darm von Psoriasis-Patienten vor und nach systemischer Behandlung mit Adalimumab bzw. Ustekinumab oder Ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. h.c. Thomas A. Luger
Stichworte
Versionen (4)
- 17.11.15 17.11.15 -
- 08.12.15 08.12.15 -
- 08.12.15 08.12.15 -
- 23.07.16 23.07.16 -
Hochgeladen am
23. Juli 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Determination Psoriasis MIPSO EudraCT 2014-003022-40 DRKS00007147
Eligibility Determination Psoriasis MIPSO EudraCT 2014-003022-40
- StudyEvent: ODM
Beschreibung
Inclusion criteria
Alias
- UMLS CUI-1
- C1512693
Beschreibung
Patients with at least moderate psoriasis vulgaris (PASI ≥ 10) plaque-type.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C4027888
Beschreibung
≥18 years (male and female)
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0001779
Beschreibung
Indications for treatment with adalimumab, ustekinumab or cyclosporine in accordance with the guidelines for psoriasis and the individual prescribing information.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1122087
- UMLS CUI [2]
- C1608841
- UMLS CUI [3]
- C0010592
Beschreibung
Patients with moderate to severe chronic plaque psoriasis who have not responded to other systemic therapy including cyclosporine, methotrexate or PUVA or who have a contraindication or intolerance to such therapy exists.
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C1524062
- UMLS CUI [1,2]
- C1512693
- UMLS CUI [1,3]
- C1122087
- UMLS CUI [2,1]
- C1524062
- UMLS CUI [2,2]
- C1512693
- UMLS CUI [2,3]
- C1608841
Beschreibung
Patients with at least moderate psoriasis vulgaris (PASI ≥ 10) plaque-type, which are not sufficiently treated with conventional systemic therapy.
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C1524062
- UMLS CUI [1,2]
- C1512693
- UMLS CUI [1,3]
- C0010592
Beschreibung
Exclusion criteria
Alias
- UMLS CUI-1
- C0680251
Beschreibung
Therapy with systemic immunosuppressants (such as cyclosporine or methotrexate), adalimumab, etanercept, infliximab, or ustekinumab in a period of 5 half-lives of the respective medication before taking the initial swab specimens / biopsies.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0021079
- UMLS CUI [1,2]
- C0205373
Beschreibung
Concurrent therapy with systemic immunosuppressants.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0009429
- UMLS CUI [1,2]
- C0021079
- UMLS CUI [1,3]
- C0205373
Beschreibung
Antibiotic therapy over a period of at least 4 weeks before taking the initial swab specimens / biopsies or antibiotic therapy during the study.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0338237
Beschreibung
Psoriasis patients who currently receive or have received phototherapy for a period of 2 weeks before the withdrawal of the initial swab specimens / biopsies.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0031765
Beschreibung
Patients who can not interrupt the local, topical therapy with calcineurin inhibitors or vitamin D3 analogues in the conditions laid down for the smear preparations / biopsies skin areas. The topical treatment with calcineurin inhibitors or vitamin D3 analogs can be continued in lesional skin areas that are not intended for smear preparations / biopsies. In the conditions laid down for the smear preparations / biopsies skin areas must be done 7 days prior to taking the samples no topical therapy.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C3888969
Beschreibung
Clinically significant active infection (eg active tuberculosis or other severe infections such as sepsis and opportunistic infections). Latent tuberculosis. A history of latent or active tuberculosis that has not been adequately treated safely.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0009450
Beschreibung
Chronic carriers of the hepatitis B virus (HBsAg positive).
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0149709
Beschreibung
HIV-positive patients.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0019699
Beschreibung
Malignancies current or history.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0006826
Beschreibung
Immunodeficient patients (primary disease or as a result of therapy).
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0021051
Beschreibung
Patients receiving chemotherapy or radiation therapy or currently one who received chemotherapy / radiotherapy within the last 12 months before the withdrawal of the initial swab specimens / biopsies.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C1522449
Beschreibung
Patients are not stable with uncontrolled chronic diseases that require continuous treatment (such as diabetes, hepatitis, organ transplantation), and from the perspective of the investigator.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0008679
- UMLS CUI [1,2]
- C0205318
Beschreibung
Patients with other chronic skin diseases such as atopic dermatitis or lupus erythematosus that may affect the cutaneous microbiota.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1290009
Beschreibung
Patients with psychiatric comorbidity, which cause a lack or lack of capacity to consent.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0004936
- UMLS CUI [1,2]
- C0009488
Beschreibung
Participation in another interventional examination before study completion in a period of 4 weeks and 5 half-lives of the former investigational, whichever is longer.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C2348568
Beschreibung
For childbearing women or men with female partners of childbearing unwillingness reliable forms of contraception (Pearl index <1) apply. With Stelara® patients treated these contraceptive methods have to at least 15 weeks after the end of treatment with Humira® patients treated for at least 5 months after the end of treatment continue.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Beschreibung
Patients who were positive for MRSA in the history over a period of 6 months prior to withdrawal of the first swab specimens / biopsies.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0343401
Beschreibung
Patients with psoriasis vulgaris exclusively in the head area.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0263361
- UMLS CUI [1,2]
- C0018670
Beschreibung
Additional exclusion criteria Adalimumab
Alias
- UMLS CUI-1
- C0680251
- UMLS CUI-2
- C1122087
Beschreibung
Hypersensitivity to the active substance or to any of the excipients of Humira®.
Datentyp
integer
Alias
- UMLS CUI [1]
- C0020517
Beschreibung
Moderate to severe heart failure (NYHA class III / IV).
Datentyp
integer
Alias
- UMLS CUI [1]
- C1275491
Beschreibung
Pre-existing or incipient demyelinating diseases of the CNS or peripheral nervous system.
Datentyp
integer
Alias
- UMLS CUI [1]
- C0751873
Beschreibung
Concurrent therapy with anakinra or abatacept.
Datentyp
integer
Alias
- UMLS CUI [1]
- C0245109
- UMLS CUI [2]
- C1619966
Beschreibung
Concomitant vaccination with live vaccines. This applies for a period up to 5 months after end of therapy.
Datentyp
integer
Alias
- UMLS CUI [1]
- C0042196
Beschreibung
Additional exclusion criteria Ustekinumab
Alias
- UMLS CUI-1
- C0680251
- UMLS CUI-2
- C1608841
Beschreibung
Hypersensitivity to the active substance or to any of the excipients of Stelara®, allergy to latex.
Datentyp
integer
Alias
- UMLS CUI [1]
- C0020517
Beschreibung
Simultaneous vaccination with live viruses or live bacteria. This applies for a period of 2 weeks prior to initiation of therapy with Stelara® until at least 15 weeks after end of therapy.
Datentyp
integer
Alias
- UMLS CUI [1]
- C0042196
Beschreibung
Additional exclusion criteria Cyclosporine
Alias
- UMLS CUI-1
- C0680251
- UMLS CUI-2
- C0010592
Beschreibung
Known hypersensitivity to ciclosporin and / or against any of the excipients of the ciclosporin preparation.
Datentyp
integer
Alias
- UMLS CUI [1]
- C0020517
Beschreibung
Uncontrolled arterial hypertension.
Datentyp
integer
Alias
- UMLS CUI [1]
- C1868885
Beschreibung
Uncontrolled infectious diseases.
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0009450
- UMLS CUI [1,2]
- C0205318
Beschreibung
Not healed infection with varicella, incl. Herpes zoster infection, herpes simplex infections, and other viral infections (eg, mollusks, condyloma, multiple warts)
Datentyp
integer
Alias
- UMLS CUI [1]
- C0586989
Beschreibung
Relevant renal impairment
Datentyp
integer
Alias
- UMLS CUI [1]
- C1565489
Beschreibung
Severe liver disease, GOT> 2 x ULN, GPT> 2x ULN, yGT> 2 x ULN, bilirubin> 2 x ULN
Datentyp
integer
Alias
- UMLS CUI [1]
- C3829821
Beschreibung
Hyperuricemia
Datentyp
integer
Alias
- UMLS CUI [1]
- C0740394
Beschreibung
Hyperkalemia
Datentyp
integer
Alias
- UMLS CUI [1]
- C0020461
Beschreibung
State after prior PUVA therapy with cumulative dose> 1000 J / cm²
Datentyp
integer
Alias
- UMLS CUI [1]
- C0853073
Beschreibung
State after many years of methotrexate therapy
Datentyp
integer
Alias
- UMLS CUI [1]
- C0025677
Beschreibung
Therapy with Etretinate within 4 weeks prior to initiating therapy with cyclosporine
Datentyp
integer
Alias
- UMLS CUI [1]
- C0015137
Beschreibung
Concurrent therapy with retinoids
Datentyp
integer
Alias
- UMLS CUI [1]
- C3653550
Beschreibung
Concurrent therapy with coal tar
Datentyp
integer
Alias
- UMLS CUI [1]
- C0009137
Beschreibung
Concurrent therapy with simvastatin
Datentyp
integer
Alias
- UMLS CUI [1]
- C0074554
Beschreibung
Concurrent therapy with tacrolimus
Datentyp
integer
Alias
- UMLS CUI [1]
- C0085149
Beschreibung
Concomitant use of St. John's wort (Hypericum perforatum)
Datentyp
integer
Alias
- UMLS CUI [1]
- C0936242
Beschreibung
Concomitant therapy with drugs that are substrates of multidrug efflux transporters P-glycoprotein or Organic Anion Transporting Polypeptides and are joined for the increased plasma concentrations with serious and / or life-threatening events, such as Bosentan, Dabigatran-Etexilate and Aliskiren.
Datentyp
integer
Alias
- UMLS CUI [1]
- C0069906
- UMLS CUI [2]
- C0949791
Beschreibung
Concomitant vaccination with live vaccines
Datentyp
integer
Alias
- UMLS CUI [1]
- C0042196
Beschreibung
Alcohol disease, contraindication to the use of alcohol (eg. epilepsy)
Datentyp
integer
Alias
- UMLS CUI [1]
- C0038586
Beschreibung
Erythrodermic or pustular psoriasis
Datentyp
integer
Alias
- UMLS CUI [1]
- C0748052
- UMLS CUI [2]
- C0152081
Beschreibung
Psoriatic forms that may be caused or exacerbated by drugs.
Datentyp
integer
Alias
- UMLS CUI [1]
- C1304130
Ähnliche Modelle
Eligibility Determination Psoriasis MIPSO EudraCT 2014-003022-40
- StudyEvent: ODM
C1710477 (UMLS CUI [1,2])
C1608841 (UMLS CUI [2])
C0010592 (UMLS CUI [3])
C1512693 (UMLS CUI [1,2])
C1122087 (UMLS CUI [1,3])
C1524062 (UMLS CUI [2,1])
C1512693 (UMLS CUI [2,2])
C1608841 (UMLS CUI [2,3])
C1512693 (UMLS CUI [1,2])
C0010592 (UMLS CUI [1,3])
C0205373 (UMLS CUI [1,2])
C0021079 (UMLS CUI [1,2])
C0205373 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2])
C0205318 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])
C0018670 (UMLS CUI [1,2])
C1122087 (UMLS CUI-2)
C1619966 (UMLS CUI [2])
C1608841 (UMLS CUI-2)
C0010592 (UMLS CUI-2)
C0205318 (UMLS CUI [1,2])
C0949791 (UMLS CUI [2])
C0152081 (UMLS CUI [2])